• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Critical serum concentration of antibiotics. A therapeutic tool and means of comparative evaluation].

作者信息

Potel G, Caillon J, Xiong Y Q, Bugnon D, Conte P L, Drugeon H B, Baron D

出版信息

Presse Med. 1995 Apr 29;24(16):750-2.

PMID:7784412
Abstract

It is difficult to predict the clinical activity of antibiotics solely on the basis of in vitro data. Experimental models measuring the relationship between serum concentration and in vivo activity are essential for comparing the activity of different compounds currently available. The critical serum concentration can be used to compare the intrinsic activity of antibiotics on a given bacterial strain. When compared with the minimal inhibiting concentration measured in vitro, "activity loss" can be determined for each antibiotic placed in contact with bacteria in an infected tissue. The relevance of this therapeutic tool in comparison with other methods is discussed.

摘要

相似文献

1
[Critical serum concentration of antibiotics. A therapeutic tool and means of comparative evaluation].
Presse Med. 1995 Apr 29;24(16):750-2.
2
In vivo bactericidal activities of ciprofloxacin and pefloxacin in an experimental model of Serratia marcescens endocarditis.环丙沙星和培氟沙星在粘质沙雷氏菌心内膜炎实验模型中的体内杀菌活性。
Antimicrob Agents Chemother. 1994 Apr;38(4):883-5. doi: 10.1128/AAC.38.4.883.
3
Zymar (Gatifloxacin 0.3%) shows excellent Gram-negative activity against Serratia marcescens and Pseudomonas aeruginosa in a New Zealand White rabbit keratitis model.在新西兰白兔角膜炎模型中,Zymar(加替沙星0.3%)对粘质沙雷氏菌和铜绿假单胞菌显示出优异的革兰氏阴性菌活性。
Cornea. 2007 Jun;26(5):585-8. doi: 10.1097/ICO.0b013e318033a6f2.
4
Comparative efficacies of ciprofloxacin and pefloxacin alone or in combination with fosfomycin in experimental endocarditis induced by multidrug-susceptible and -resistant Pseudomonas aeruginosa.环丙沙星和培氟沙星单独使用或与磷霉素联合使用在多药敏感和耐药铜绿假单胞菌引起的实验性心内膜炎中的比较疗效。
Antimicrob Agents Chemother. 1995 Feb;39(2):496-9. doi: 10.1128/AAC.39.2.496.
5
Differential distributions in tissues and efficacies of aztreonam and ceftazidime and in vivo bacterial morphological changes following treatment.氨曲南和头孢他啶在组织中的差异分布、疗效以及治疗后体内细菌形态变化
Antimicrob Agents Chemother. 1997 Feb;41(2):401-9. doi: 10.1128/AAC.41.2.401.
6
Efficacy of ciprofloxacin in experimental aortic valve endocarditis caused by a multiply beta-lactam-resistant variant of Pseudomonas aeruginosa stably derepressed for beta-lactamase production.环丙沙星对由一株稳定去阻遏产β-内酰胺酶的多重β-内酰胺耐药铜绿假单胞菌变种引起的实验性主动脉瓣心内膜炎的疗效。
Antimicrob Agents Chemother. 1986 Oct;30(4):528-31. doi: 10.1128/AAC.30.4.528.
7
The importance of pharmacodynamics in determining the dosing interval in therapy for experimental pseudomonas endocarditis in the rat.药效学在确定大鼠实验性假单胞菌性心内膜炎治疗给药间隔中的重要性。
J Infect Dis. 1986 Apr;153(4):707-14. doi: 10.1093/infdis/153.4.707.
8
[Ceftazidime in the treatment of meningitis caused by multiresistant Serratia marcescens].头孢他啶治疗多重耐药粘质沙雷氏菌引起的脑膜炎
Jpn J Antibiot. 1992 Oct;45(10):1275-81.
9
In vivo antibacterial effects of simulated human serum profiles of once-daily versus thrice-daily dosing of amikacin in a Serratia marcescens endocarditis experimental model.在粘质沙雷氏菌心内膜炎实验模型中,每日一次与每日三次给药的阿米卡星模拟人体血清谱的体内抗菌效果。
Antimicrob Agents Chemother. 1996 May;40(5):1164-9. doi: 10.1128/AAC.40.5.1164.
10
Bactericidal effect of pefloxacin and fosfomycin against Pseudomonas aeruginosa in a rabbit endocarditis model with pharmacokinetics of pefloxacin in humans simulated in vivo.在模拟人体培氟沙星药代动力学的兔心内膜炎模型中,培氟沙星和磷霉素对铜绿假单胞菌的杀菌作用。
Eur J Clin Microbiol Infect Dis. 1997 Aug;16(8):575-80. doi: 10.1007/BF02447919.